Phase III Multicenter Placebo-Controlled Study of Tamsulosin in Benign Prostatic Hyperplasia
Open Access
- 1 June 1998
- Vol. 51 (6) , 892-900
- https://doi.org/10.1016/s0090-4295(98)00126-5
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Side Effects of Terazosin in the Treatment of Symptomatic Benign Prostatic HyperplasiaSouthern Medical Journal, 1997
- Prostatic α1-adrenoceptors and uroselectivityThe Prostate, 1997
- The Efficacy of Terazosin, Finasteride, or Both in Benign Prostatic HyperplasiaNew England Journal of Medicine, 1996
- Prostate Selectivity of Alpha-Blockers: From Receptor Biology to Clinical MedicineEuropean Urology, 1996
- Localization of the alpha 1A-Adrenoceptor in the Human ProstateJournal of Urology, 1995
- Safety assessment of terazosin in thetreatment of patients with symptomatic benign prostatic hyperplasia: A combined analysisUrology, 1994
- Medical therapy for benign prostatic hyperplasiaUrology, 1993
- A Randomized, Placebo-Controlled Multicenter Study of the Efficacy and Safety of Terazosin in the Treatment of Benign Prostatic HyperplasiaJournal of Urology, 1992
- Bladder Outflow Obstruction Treated with PhenoxybenzamineBritish Journal of Urology, 1982
- A Placebo‐controlled Double‐blind Study of the Effect of Phenoxybenzamine in Benign Prostatic ObstructionBritish Journal of Urology, 1978